| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000231889.3 |
Tanespimycin |
Brain lower grade glioma |
0.030925712 |
Resistant |
| ENSG00000231889.3 |
Tanespimycin |
Lung squamous cell carcinoma |
0.002255606 |
Resistant |
| ENSG00000231889.3 |
Tanespimycin |
Thyroid carcinoma |
0.04613942 |
Resistant |
| ENSG00000231889.3 |
Tanespimycin |
Colon adenocarcinoma |
0.036259199 |
Sensitive |
